EXCHANGE AGREEMENTExchange Agreement • June 29th, 2016 • AntriaBio, Inc. • Pharmaceutical preparations • Delaware
This EXCHANGE AGREEMENT (the “Agreement”) is made as of the ___ day of May 2016, by and between, AntriaBio, Inc., a Delaware corporation (the “Company”), and the investor signatory hereto (the “Investor”).
PURCHASE AGREEMENTPurchase Agreement • June 29th, 2016 • AntriaBio, Inc. • Pharmaceutical preparations • Delaware
The undersigned (the “Purchaser”) hereby irrevocably agrees to purchase from AntriaBio, Inc. (the “Company”) that number of (i) Class A Units (“Class A Units”) and/or (ii) Class B Units, if applicable (the “Class B Units” together with the Class A Units, the “Units”), set out below at a price of $1.10 per Unit. Each Class A Unit consists of one share of common stock and one-half of one warrant (each whole warrant, a “Warrant”). Eligible Purchasers of the Class B Units are those Purchasers that invest at least $50,000 in this Offering and have participated in a prior Company offering during the Period (as defined herein) and either, (i) invested at least $200,000 in a prior Company offering during the Period (as defined herein), or (ii) invest at least 25% of the amount such Purchaser invested in a prior Company offering during the Period in this Offering. Each Class B Unit consists of one share of common stock and one Warrant. The Purchaser agrees to be bound by the terms and condition
